Application Nr Approved Date Route Status External Links
ANDA209361 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications & Usage Clobetasol Propionate Topical Solution Is Indicated For Short-Term Topical Treatment Of Inflammatory And Pruritic Manifestations Of Moderate To Severe Corticosteroid-Responsive Dermatoses Of The Scalp. Treatment Beyond 2 Consecutive Weeks Is Not Recommended, And The Total Dosage Should Not Exceed 50 Ml/week Because Of The Potential For The Drug To Suppress The Hpa Axis. This Product Is Not Recommended For Use In Pediatric Patients Under 12 Years Of Age.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Clobetasol Propionate CLOBETASOL PROPIONATE ZINC3977767

Comments